NCT01607671View on ClinicalTrials.gov

Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Optic Neuropathy, IschemicAnterior Ischemic Optic NeuropathyIschemic Optic NeuropathyOptic Neuropathy, Anterior Ischemic
Interventions
DRUG

Timolol maleate

Timolol 0.5% 1 drop twice daily to the effected eye for 4 weeks.

Trial Locations (1)

V3T 0G9

Jim Pattison Outpatient Care and Surgery Centre, 3C Neurology, Surrey

Sponsors

Lead Sponsor

Fraser Health
All Listed Sponsors
lead

Fraser Health

OTHER